Long-term impact of treatment in women diagnosed with bulimia nervosa
- PMID: 11920976
- DOI: 10.1002/eat.10017
Long-term impact of treatment in women diagnosed with bulimia nervosa
Abstract
Objective: Both cognitive-behavioral therapy (CBT) and antidepressant medication have demonstrated efficacy in the treatment of bulimia nervosa. However, data concerning the long-term impact of such treatments have been limited. This study sought to determine if treatment with CBT and antidepressant medication was associated with better long-term outcome among women diagnosed with bulimia nervosa.
Method: Women (N = 101) who completed a controlled treatment study of bulimia nervosa participated in follow-up assessments approximately 10 years later.
Results: Women who received treatment with CBT or antidepressant medication or both reported improved social adjustment at long-term follow-up compared with women randomized to the placebo condition.
Discussion: Treatments with demonstrated efficacy for short-term outcome appear to improve psychosocial function at long-term follow-up among women initially diagnosed with bulimia nervosa.
Copyright 2002 by Wiley Periodicals, Inc.
Similar articles
-
A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments.Arch Gen Psychiatry. 1995 Apr;52(4):304-12. doi: 10.1001/archpsyc.1995.03950160054010. Arch Gen Psychiatry. 1995. PMID: 7702447 Clinical Trial.
-
Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy.Arch Gen Psychiatry. 1993 Jun;50(6):419-28. doi: 10.1001/archpsyc.1993.01820180009001. Arch Gen Psychiatry. 1993. PMID: 8498876 Clinical Trial.
-
Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.JAMA. 2000 May 17;283(19):2529-36. doi: 10.1001/jama.283.19.2529. JAMA. 2000. PMID: 10815116 Clinical Trial.
-
A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa.Int J Eat Disord. 1993 Nov;14(3):229-47. doi: 10.1002/1098-108x(199311)14:3<229::aid-eat2260140302>3.0.co;2-x. Int J Eat Disord. 1993. PMID: 8275060 Review.
-
Pharmacotherapy of bulimia nervosa and binge eating disorder: longer-term outcomes.Psychopharmacol Bull. 1997;33(3):433-6. Psychopharmacol Bull. 1997. PMID: 9550889 Review.
Cited by
-
Psychodermatology: a guide to understanding common psychocutaneous disorders.Prim Care Companion J Clin Psychiatry. 2007;9(3):203-13. doi: 10.4088/pcc.v09n0306. Prim Care Companion J Clin Psychiatry. 2007. PMID: 17632653 Free PMC article.
-
Dopamine and binge eating behaviors.Pharmacol Biochem Behav. 2010 Nov;97(1):25-33. doi: 10.1016/j.pbb.2010.04.016. Epub 2010 Apr 24. Pharmacol Biochem Behav. 2010. PMID: 20417658 Free PMC article. Review.
-
Antidepressants versus placebo for people with bulimia nervosa.Cochrane Database Syst Rev. 2001;2003(4):CD003391. doi: 10.1002/14651858.CD003391. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2003;(4):CD003391. doi: 10.1002/14651858.CD003391. PMID: 11687198 Free PMC article. Updated.
-
Psychological treatments for bulimia nervosa and binging.Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD000562. doi: 10.1002/14651858.CD000562.pub3. Cochrane Database Syst Rev. 2009. PMID: 19821271 Free PMC article.
-
Psychosocial functioning in patients with Treatment-Resistant Depression after group cognitive behavioral therapy.BMC Psychiatry. 2010 Mar 16;10:22. doi: 10.1186/1471-244X-10-22. BMC Psychiatry. 2010. PMID: 20230649 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources